Patents by Inventor Véronique HENDERICKX

Véronique HENDERICKX has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HPV VACCINE MANUFACTURE
    Publication number: 20240131140
    Abstract: Described are methods for the preparation of a HPV vaccine composition by, for example (i) adsorbing one or more HPV antigen(s) on a metallic salt and, then (ii) adding a non adsorbed glycolipid based TLR4 ligand to the mixture obtained in (i). Resulting HPV vaccine compositions and uses thereof are also described.
    Type: Application
    Filed: February 9, 2022
    Publication date: April 25, 2024
    Applicants: GLAXOSMITHKLINE BIOLOGICALS SA, XIAMEN INNOVAX BIOTECH CO., LTD.
    Inventors: Babak BAYAT, Véronique HENDERICKX, Bram VUYLSTEKE
  • ADJUVANT COMPOSITIONS COMPRISING A NON-IONIC ISOTONICITY AGENT
    Publication number: 20180021417
    Abstract: The present invention relates to an aqueous adjuvant composition comprising a TLR-4 agonist and a saponin in a liposomal formulation and a non-ionic isotonicity agent having low salt concentrations.
    Type: Application
    Filed: July 10, 2017
    Publication date: January 25, 2018
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, SA
    Inventors: Veronique Henderickx, Dominique Ingrid Lemoine
  • INACTIVATED DENGUE VIRUS VACCINE
    Publication number: 20140112953
    Abstract: The present invention provides formulations of an immunogenic composition containing a purified inactivated Dengue virus, and method for producing them.
    Type: Application
    Filed: May 25, 2012
    Publication date: April 24, 2014
    Applicant: Glaxo SmithKline Biologicals sa
    Inventors: Veronique Henderickx, Olivier Le Bussy, Dominique Ingrid Lemoine, Frederic Mathot
  • IMMUNOGENIC COMPOSITIONS HAVING LOW SODIUM CHLORIDE CONCENTRATION
    Publication number: 20120093921
    Abstract: Immunogenic compositions comprising an antigen, wherein the concentration of sodium chloride or the ionic strength of the composition is less than 100 mM, and their use in medicine, are provided.
    Type: Application
    Filed: June 8, 2010
    Publication date: April 19, 2012
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Veronique Henderickx, Dominique Ingrid Lemoine
  • ADJUVANT COMPOSITIONS COMPRISING A NON-IONIC ISOTONICITY AGENT
    Publication number: 20120087976
    Abstract: The present invention relates to an aqueous adjuvant composition comprising a TLR-4 agonist and a saponin in a liposomal formulation and a non-ionic isotonicity agent having low salt concentrations.
    Type: Application
    Filed: June 8, 2010
    Publication date: April 12, 2012
    Inventors: Veronique Henderickx, Dominique Ingrid Lemoine
  • Vaccine Compositions Comprising Virosomes and a Saponin Adjuvant
    Publication number: 20090263470
    Abstract: This invention provides virosome preparations from an enveloped virus, in particular from influenza virus, containing from said virus, and a saponin adjuvant. In particular the invention provides a virosome preparation from influenza virus an influenza antigen a QS21, optionally with a sterol. The invention also provides vaccine compositions containing said virosome preparations, methods of preparing said virosome preparations and vaccine containing them.
    Type: Application
    Filed: May 26, 2005
    Publication date: October 22, 2009
    Inventors: Beth-Ann Coller, Veronique Henderickx, Nathalie Marie-Josephe Garcon
  • Novel vaccine
    Publication number: 20090155309
    Abstract: The invention relates to the use of a non-live influenza virus antigen preparation, particularly a split influenza virus preparation, in the manufacture of a vaccine formulation for a one-dose intranasal vaccination against influenza, wherein the one-dose vaccination meets international regulatory requirements for influenza vaccines. Further provided are methods for the production of the vaccine, and a pharmaceutical kit comprising an intranasal administration device and the one-dose vaccine.
    Type: Application
    Filed: February 18, 2009
    Publication date: June 18, 2009
    Inventors: Martin Friede, Veronique Henderickx, Philippe Hermand, Moncef Mohamed Saloui, Sefan Gabriel Jozef Thoelen
  • Intranasal influenza virus vaccine
    Publication number: 20050201946
    Abstract: Aminopiperidine derivatives and pharmaceutically acceptable derivatives thereof are disclosed. Such derivatives are useful in methods of treatment of bacterial infections in mammals, particularly in man.
    Type: Application
    Filed: May 2, 2005
    Publication date: September 15, 2005
    Inventors: Martin Friede, Veronique Henderickx, Philippe Hermand, Moncef Slaoui, Stefan Thoelen